270 related articles for article (PubMed ID: 31399066)
1. Chart validation of an algorithm for identifying hereditary progressive muscular dystrophy in healthcare claims.
Chen X; Agiro A; Martin AS; Lucas AM; Haynes K
BMC Med Res Methodol; 2019 Aug; 19(1):174. PubMed ID: 31399066
[TBL] [Abstract][Full Text] [Related]
2. Development and electronic health record validation of an algorithm for identifying patients with Duchenne muscular dystrophy in US administrative claims.
Schrader R; Posner N; Dorling P; Senerchia C; Chen Y; Beaverson K; Seare J; Garnier N; Walker V; Alvir J; Mahn M; Merla V; Zhang Y; Landis C; Buikema AR
J Manag Care Spec Pharm; 2023 Sep; 29(9):1033-1044. PubMed ID: 37610111
[No Abstract] [Full Text] [Related]
3. Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.
Do TN; Street N; Donnelly J; Adams MM; Cunniff C; Fox DJ; Weinert RO; Oleszek J; Romitti PA; Westfield CP; Bolen J;
Birth Defects Res; 2018 Nov; 110(19):1404-1411. PubMed ID: 30070776
[TBL] [Abstract][Full Text] [Related]
4. Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity.
Soslow JH; Hall M; Burnette WB; Hor K; Chisolm J; Spurney C; Godown J; Xu M; Slaughter JC; Markham LW
Cardiol Young; 2019 Mar; 29(3):290-296. PubMed ID: 30683166
[TBL] [Abstract][Full Text] [Related]
5. Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy.
Mathews KD; Cunniff C; Kantamneni JR; Ciafaloni E; Miller T; Matthews D; Cwik V; Druschel C; Miller L; Meaney FJ; Sladky J; Romitti PA
J Child Neurol; 2010 Sep; 25(9):1098-102. PubMed ID: 20817884
[TBL] [Abstract][Full Text] [Related]
6. Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients.
Curtis JR; Chen SY; Werther W; John A; Johnson DA
Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1150-8. PubMed ID: 22020901
[TBL] [Abstract][Full Text] [Related]
7. Performance of claims-based algorithms for identifying incident thyroid cancer in commercial health plan enrollees receiving antidiabetic drug therapies.
Funch D; Ross D; Gardstein BM; Norman HS; Sanders LA; Major-Pedersen A; Gydesen H; Dore DD
BMC Health Serv Res; 2017 May; 17(1):330. PubMed ID: 28476125
[TBL] [Abstract][Full Text] [Related]
8. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
[TBL] [Abstract][Full Text] [Related]
9. Age at onset of first signs or symptoms predicts age at loss of ambulation in Duchenne and Becker Muscular Dystrophy: Data from the MD STARnet.
Ciafaloni E; Kumar A; Liu K; Pandya S; Westfield C; Fox DJ; Caspers Conway KM; Cunniff C; Mathews K; West N; Romitti PA; McDermott MP
J Pediatr Rehabil Med; 2016; 9(1):5-11. PubMed ID: 26966795
[TBL] [Abstract][Full Text] [Related]
10. Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy.
Holtzer C; Meaney FJ; Andrews J; Ciafaloni E; Fox DJ; James KA; Lu Z; Miller L; Pandya S; Ouyang L; Cunniff C
Genet Med; 2011 Nov; 13(11):942-7. PubMed ID: 21836521
[TBL] [Abstract][Full Text] [Related]
11. Oral health considerations in muscular dystrophies.
Balasubramaniam R; Sollecito TP; Stoopler ET
Spec Care Dentist; 2008; 28(6):243-53. PubMed ID: 19068065
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a case definition for epilepsy for use with administrative health data.
Reid AY; St Germaine-Smith C; Liu M; Sadiq S; Quan H; Wiebe S; Faris P; Dean S; Jetté N
Epilepsy Res; 2012 Dec; 102(3):173-9. PubMed ID: 22727659
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
Chung CP; Rohan P; Krishnaswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5-24 years - four states, 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(40):1119-22. PubMed ID: 19834452
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database.
Lyons J; Desai V; Xu Y; Ridgeway G; Finkle W; Solari P; Sullivan S; Lanes S
Value Health; 2018 Sep; 21(9):1098-1103. PubMed ID: 30224115
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of validated methods for identifying systemic lupus erythematosus (SLE) using administrative or claims data.
Moores KG; Sathe NA
Vaccine; 2013 Dec; 31 Suppl 10():K62-73. PubMed ID: 24331075
[TBL] [Abstract][Full Text] [Related]
17. Identifying perianal fistula complications in pediatric patients with Crohn's disease using administrative claims.
Adler J; Jary HK; Eder SJ; Dong S; Brandt E; Haraga JK; Dombkowski KJ
PLoS One; 2019; 14(8):e0219893. PubMed ID: 31412045
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Duchenne and Becker muscular dystrophies in the United States.
Romitti PA; Zhu Y; Puzhankara S; James KA; Nabukera SK; Zamba GK; Ciafaloni E; Cunniff C; Druschel CM; Mathews KD; Matthews DJ; Meaney FJ; Andrews JG; Conway KM; Fox DJ; Street N; Adams MM; Bolen J;
Pediatrics; 2015 Mar; 135(3):513-21. PubMed ID: 25687144
[TBL] [Abstract][Full Text] [Related]
19. Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).
Ciafaloni E; Fox DJ; Pandya S; Westfield CP; Puzhankara S; Romitti PA; Mathews KD; Miller TM; Matthews DJ; Miller LA; Cunniff C; Druschel CM; Moxley RT
J Pediatr; 2009 Sep; 155(3):380-5. PubMed ID: 19394035
[TBL] [Abstract][Full Text] [Related]
20. Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population.
Wahl PM; Terrell DR; George JN; Rodgers JK; Uhl L; Cataland S; Bohn RL
Thromb Haemost; 2010 Jun; 103(6):1203-9. PubMed ID: 20352159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
